Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data. (Q34269947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

angiogenesis inhibitor

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

R E Port

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

16 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

118-124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22588603%20AND%20SRC:MED&resulttype=core&format=json

MRI of tumor angiogenesis

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Gadolinium-induced nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Issues of discontinuity in the impulse residue function for deconvolution analysis of dynamic contrast-enhanced MRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Key factors in the acquisition of contrast kinetic data for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

A new approach to analysis of the impulse response function (IRF) in dynamic contrast-enhanced MRI (DCEMRI): a simulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

7 January 2021

Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

7 January 2021

Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

7 January 2021

Quantification of viable tumor microvascular characteristics by multispectral analysis.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.63

7 January 2021